Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

AACR Congratulates Two Members on Their Election Into the National Academy of Sciences

May 16, 2011 12:32 pm | by AACR | News | Comments

Tweet   PHILADELPHIA - The American Association for Cancer Research congratulates two of its members, Ira Mellman, Ph.D., and Luis F. Parada, Ph.D., on their election to the National Academy of Sciences. “We are very proud to announce the election of these two distinguished AACR...

VIDA Diagnostics Launches Apollo Pulmonary Analysis Software for Major Lung Disease at American Thoracic Society Meeting

May 16, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

DENVER, May 16, 2011 /- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today the launch of its new Apollo™ Software for the evaluation of pulmonary disease including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer,...

Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150®

May 16, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich., May 16, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Ranitidine 150 (regular and cool mint), a generic...

Advertisement

Arstasis Launches New AXERAâ„¢ Access Device in the U.S.

May 16, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 16, 2011 /- Arstasis is pleased to announce the U.S. launch of its latest commercial product - the AXERA™ Access Device.  The AXERA Device enhances insertability into the femoral artery and overall procedural usage while continuing to deliver the...

diaDexus, Inc. Reports 2011 First Quarter Financial Results

May 16, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., May 16, 2011 /- diaDexus, Inc. (OTC Bulletin Board: DDXS ), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial...

HYCOR Expands Board of Directors to Support Growth in Key Areas

May 16, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

GARDEN GROVE, Calif., May 16, 2011 /- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets, together with owner Linden, LLC, today announced the appointments of Vijay Aggarwal, Ph.D. and James...

Siemens Showcases New Innovations in Clinical Diagnostics, Automation, and IT at IFCC-WorldLab Berlin 2011

May 16, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

BERLIN, May 16, 2011 /- Siemens Healthcare Diagnostics is showcasing a broad spectrum of its clinical diagnostics portfolio, including a focus on scalable l ab automation solutions, at the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) WorldLab 2011 in...

Amnis Introduces New FlowSight Imaging Flow Cytometer

May 13, 2011 9:39 am | by Bio-Medicine.Org | News | Comments

SEATTLE, May 13, 2011 /- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the launch of the new FlowSight imaging flow cytometer. The FlowSight is a compact and affordable 12-channel flow cytometer with unrivalled fluorescence sensitivity and the...

Advertisement

Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)

May 13, 2011 4:45 am | by Bio-Medicine.Org | News | Comments

NEWPORT NEWS, Va., May 13, 2011 /- The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in...

REMINDER: PositiveID Corporation to Host Conference Call and Webcast to Discuss Its Acquisition of MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applica...

May 12, 2011 8:35 am | by PositiveID | News | Comments

REMINDER: PositiveID Corporation to Host Conference Call and Webcast to Discuss Its Acquisition of MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applications

Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today

May 12, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

OMAHA, Neb., May 12, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:What: Transgenomic, Inc. First Quarter 2011 Financial Results and Business Update Conference CallWhen: Thursday, May 12, 2011 @ 5:00 p.m. EasternWhere:...

Abstracts Reporting EarlyCDTâ„¢-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers

May 12, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

DENVER, May 12, 2011 /- Oncimmune ® LLC , maker of EarlyCDT™-Lung , a simple blood test that aids physicians in the risk assessment and early detection of lung cancer , today announced that four poster presentations during the American Thoracic Society's (ATS) International...

How are you influencing patient management devices?

May 11, 2011 10:17 am | Articles | Comments

Rudye McGlothlin, Product Marketing Engineer at Texas Instruments, Chris Mertens, Vice President of Healthcare at HP PSG, and Alex Brisbourne, President and COO at KORE Telematics, respond to the question, “How are you influencing patient management devices?”

Advertisement

Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate

May 11, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, May 11, 2011 /- Instacare Corp. (OTCQB: ISCR), the exclusive provider of the Shasta Genstrip, a revolutionary diagnostic product targeted at the $20 billion diabetes care marketplace, a leading provider of prescription diagnostics and home testing products for the chronically...

Vemurafenib New Drug Application Submitted to FDA for Melanoma

May 11, 2011 2:31 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and TOKYO, May 11, 2011 /- Daiichi Sankyo announced that applications have been submitted for market approval for vemurafenib (PLX4032/RG7204) for the treatment of metastatic melanoma to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA)....

American Imaging Management Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection

May 10, 2011 10:32 am | by Bio-Medicine.Org | News | Comments

CHICAGO, May 10, 2011 /- American Imaging Management (AIM) was selected as one of 20 finalists for the 2011 URAC Awards for Best Practices in Health Care Consumer Empowerment and Protection. URAC, the nation's leading accreditation organization, will honor the finalists during URAC's 12th...

Vermillion Reports Financial Results for the First Quarter 2011

May 10, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, May 10, 2011 /- Vermillion, Inc . (Nasdaq: VRML ), a molecular diagnostics company, today reported financial results for the first quarter ended March 31, 2011.  Key milestones we have achieved since the last quarterly conference call include: Performed an...

Concord Medical Services Holdings to Present at Two Upcoming Conferences

May 10, 2011 3:31 am | by Bio-Medicine.Org | News | Comments

BEIJING, May 10, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it is scheduled to present at...

Radiologists Need to Contribute to Research

May 9, 2011 1:33 pm | by Diagnostic Imaging | News | Comments

Only a few radiologists understand how to make a policy case for the value of diagnostic procedures. More need to contribute to research and prove that continued coverage is worthwhile.

Knowing When Work Has Taken Over Your Life

May 9, 2011 1:33 pm | by Diagnostic Imaging | News | Comments

I recently heard some news about a colleague from my residency. He's doing quite well for himself, holding a full-time job and also covering extra hours on the side. I know more than a few full-time radiologists whose annual salaries are less than half of what he's earning, so it was a...

Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China

May 9, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., QUEENSLAND, Australia and BEIJING, May 9, 2011 /- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the formation of...

Quest Diagnostics Sponsors American Cancer Society's Choose You® Movement

May 9, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., May 9, 2011 /- Quest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX ), today announced its national sponsorship of Choose You®, the American Cancer Society's movement that inspires women to stay well by putting...

TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members

May 9, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., May 9, 2011 /- TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the appointment of Mr. Supratim Bose and Mr. Michael Kleine to their Board of Directors. Mr. Bose,...

Samsung Medison Pledges to Become a World-Class Medical Device Company

May 9, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

CYPRESS, Calif., May 9, 2011 /- Medison and Samsung Electronics jointly announced a new corporate identity of Samsung Medison. The combined company, a joint partnership between Korea's leading diagnostic ultrasound equipment manufacturer and one of the world's largest and most...

Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments

May 9, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading